Clinical Trial Update: Brexpiprazole (OPC-34712) as an Adjunctive Treatment in Adults With Major Depressive Disorder and Anxiety Symptoms [Phase 3]

View source ↗

Summary

This update reports Phase 3 results for brexpiprazole as an adjunctive treatment to antidepressants in adults with major depressive disorder and anxiety symptom…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anxiety Disorder
• Major Depressive Disorder

Drugs mentioned

• Brexpiprazole (Rexulti) (brexpiprazole)

Snippet

Sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc. | Conditions: Major Depressive Disorder, Anxiety | Phase 3 | Status: COMPLETED | Results posted: 2016-03-29